Cargando…

Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses

BACKGROUND AND AIMS: Heart failure with reduced ejection fraction (HFrEF) still carries a high risk for a sustained decrease in left ventricular ejection fraction (LVEF) even with the optimal medical therapy. Currently, there is no effective tool to stratify these patients according to their recover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiqiang, Fan, Xiude, Wu, Qihui, Liu, Jing, Wei, Linyan, Yang, Dandan, Bu, Xiang, Liu, Xiaoxiang, Ma, Aiqun, Hayashi, Tomohiro, Guan, Gongchang, Xiang, Yu, Shi, Shuang, Wang, Junkui, Fang, Jiansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334530/ https://www.ncbi.nlm.nih.gov/pubmed/35911515 http://dx.doi.org/10.3389/fcvm.2022.853870

Ejemplares similares

Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017
por: Wang, Xiqiang, et al.
Publicado: (2021)

HYDROXYCHLOROQUINE ATTENUATES HERG CHANNEL BY PROMOTING THE MEMBRANE CHANNEL DEGRADATION: EVIDENCES FOR QT-INTERVAL PROLONGATION IN COVID-19 PATIENTS WITH HYDROXYCHLOROQUINE TREATMENT
por: Wang, Xiqiang, et al.
Publicado: (2022)

Comparison of outcomes between transcatheter tricuspid valve repair and surgical tricuspid valve replacement or repair in patients with tricuspid insufficiency
por: Wang, Xiqiang, et al.
Publicado: (2023)

Global Burden of Aortic Aneurysm and Attributable Risk Factors from 1990 to 2017
por: Wei, Linyan, et al.
Publicado: (2021)

Prognostic value of culprit artery double-stranded DNA in ST-segment elevated myocardial infarction
por: Wang, Xiqiang, et al.
Publicado: (2018)

Outcomes of transcatheter edge-to-edge mitral valve repair with percutaneous coronary intervention vs. surgical mitral valve repair with coronary artery bypass grafting
por: Wang, Xiqiang, et al.
Publicado: (2022)

Epidemiological features and survival outcomes in patients with malignant pulmonary blastoma: a US population-based analysis
por: Bu, Xiang, et al.
Publicado: (2020)

The Relationship between Serum Uric Acid and Ejection Fraction of the Left Ventricle
por: Vlad-Sabin, Ivan, et al.
Publicado: (2021)

Serum uric acid: A risk factor for right ventricular dysfunction and prognosis in heart failure with preserved ejection fraction
por: Deng, Xiang-liang, et al.
Publicado: (2023)

Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
por: Nishino, Masami, et al.
Publicado: (2022)

Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction
por: Yang, Guodong, et al.
Publicado: (2019)

Prognostic value of estimated plasma volume in patients with chronic systolic heart failure
por: Lin, Yuyao, et al.
Publicado: (2021)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
por: Sinha, Aish, et al.
Publicado: (2023)

Neutrophil extracellular traps and dsDNA predict outcomes among patients with ST-elevation myocardial infarction
por: Liu, Jing, et al.
Publicado: (2019)

Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials
por: Xiang, Yajie, et al.
Publicado: (2019)

Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Association of depression with hypertensive left ventricular hypertrophy in age, sex, and education level‐specific differences
por: Shi, Shuang, et al.
Publicado: (2023)

Circulating miR-126 and miR-499 reflect progression of cardiovascular disease; correlations with uric acid and ejection fraction
por: Khanaghaei, Masoud, et al.
Publicado: (2016)

Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction
por: Kramer, Frank, et al.
Publicado: (2020)

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial( )
por: Doehner, Wolfram, et al.
Publicado: (2022)

Serum uric acid and outcome in hospitalized elderly patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes
por: Yan, Wei, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective
por: Wu, Qihui, et al.
Publicado: (2020)

Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhao, Na, et al.
Publicado: (2015)

Matrine suppresses cardiac fibrosis by inhibiting the TGF-β/Smad pathway in experimental diabetic cardiomyopathy
por: Zhang, Yong, et al.
Publicado: (2018)

TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology
por: Liu, Zhihong, et al.
Publicado: (2020)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy
por: Cai, Chuipu, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Clinical Implications of Plasma Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis
por: Shi, Yujiao, et al.
Publicado: (2022)

Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats
por: Wu, Xiang, et al.
Publicado: (2022)

Developing a taxonomy for colorectal cancer
por: Fang, Jiansong, et al.
Publicado: (2022)

DNA Methyltransferase 3b Accelerates the Process of Atherosclerosis
por: Zhu, Ling, et al.
Publicado: (2022)

Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Sotomi, Yohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ur6hgs5g7aqv6b92q5i99bdsu